Switzerland Startup Ecosystem

Overview

Switzerland's startup ecosystem is highly advanced, with Zurich and Geneva being key hubs for innovation. As of 2023, Switzerland is home to around 5,000 startups. The Swiss government supports innovation through initiatives like Innosuisse and the Swiss National Science Foundation, which provide funding, resources, and mentorship for startups. In 2022, Swiss startups raised approximately €2 billion in venture capital. These factors collectively highlight Switzerland's dynamic and evolving startup landscape.

Size of the Market

As of 2023, Switzerland's startup ecosystem includes around 5,000 startups. In 2022, these startups attracted approximately €2 billion in venture capital funding. This substantial investment underscores the ecosystem's growth potential and robust nature. The market's size and financial backing reflect its capacity to foster innovation and sustain a competitive edge within Europe and beyond.

Key Strengths

Switzerland's startup ecosystem is characterized by several key strengths, including a highly educated workforce, a strong financial sector, and world-class research institutions. The country excels in sectors such as fintech, healthtech, and cleantech. These strengths are bolstered by Switzerland's robust industrial base and government support, positioning it as a leader in the European startup scene.

Major Hubs

Zurich and Geneva are the primary hubs of Switzerland’s startup ecosystem. Zurich is known for its strengths in fintech, healthtech, and cleantech, attracting significant investments and producing notable startups like Climeworks and Nexthink. Geneva has a vibrant tech scene with strengths in biotech and international trade. These cities are instrumental in driving Switzerland's economic growth and technological advancements.

Emerging Hubs

In addition to Zurich and Geneva, emerging hubs like Lausanne and Basel are gaining prominence in Switzerland’s startup ecosystem. Lausanne, home to EPFL, is strong in deep tech and medtech, while Basel is a hub for pharmaceuticals and life sciences. These emerging hubs are expanding the reach and diversity of Switzerland’s entrepreneurial landscape, offering new opportunities for innovation and growth.

Support Systems

Switzerland’s startup ecosystem benefits from a strong network of incubators, accelerators, and co-working spaces that provide essential support and resources for entrepreneurs. Initiatives like Venturelab and the Swiss Innovation Park have significantly boosted the ecosystem by offering mentorship, resources, and international exposure. This supportive infrastructure is crucial for nurturing early-stage companies and fostering a collaborative entrepreneurial environment.

Challenges

Despite its strengths, the Swiss startup ecosystem faces challenges such as high living costs and regulatory complexities. Navigating these hurdles can be time-consuming and complex for startups. Addressing these issues requires strategic efforts and supportive policies to sustain growth and competitiveness in the global market.

Opportunities and Future Outlook

Switzerland has significant opportunities for growth in sectors like fintech, healthtech, and cleantech. The country's strong focus on sustainability and green technology drives innovation in renewable energy and environmental technologies. Switzerland's strategic location in Europe and strong trade relationships provide startups with opportunities for international expansion. With continued investment and innovation, Switzerland's startup ecosystem is poised for further growth, contributing significantly to the European and global markets.

Resilience and Adaptability

Switzerland's startup ecosystem demonstrates remarkable resilience and adaptability. The country's commitment to innovation, coupled with strong government and institutional support, enables startups to navigate challenges and capitalize on opportunities. The diverse talent pool and high level of digitalization attract entrepreneurs and investors alike, ensuring sustained growth and success in the face of global economic shifts and market dynamics.

Angel Investment trends in Switzerland

overlay landing page

We found 101 VC firms in Switzerland investing in Material Science on Angels Partners

Giovanni Leo
Investing in IT (& TMT) • Media • BioTe...
 Geneva, Switzerland
Investor Picture
Previous Investments
  • EBAMed: (early stage)
  • Innogest Capital:
  • MedLumics, S.L.: (late stage)
  • Anaconda BioMed: (early stage)
  • CV Lab - Cardiovascular Laboratory: (early stage)
  • Medyria: (early stage)
  • Endosense: (early stage)
  • ISO-MET:
  • CTERA Networks:
  • Silverfort Security:
  • Cato Networks: (early stage)
  • Fireglass: (early stage)
  • Teridion: (early stage)
  • Singtel Innov8 Ventures LLC:
  • Carmel Ventures:

Giovanni Leo

Geneva, Switzerland

Investing In

IT (& TMT) • Media • BioTech • Energy • CleanTech • Web Security (& Privacy) • Material Science • Medical Devices (& Hospital Services)

Description

Partner at Innogest Capital

Partner at Innogest Capital

Swisscom Ventures
Investing in Software (Web Marketplace Saas..) &b...
 Zurich - Geneva, Switzerland
  • main investor picture
    Carlo Grassi
    Financial Manager
  • main investor picture
    Stefan Kuentz
    Investment Partner
  • main investor picture
    Dominique Megret
    Head of Swisscom Ventures
  • main investor picture
    Alexander Schlaepfer
    Investment Partner
  • main investor picture
    Pär Lange
    Investment Partner
  • main investor picture
    Klea Gorgievski
    Investment Manager
  • main investor picture
    Duminique Megret
    Partner
Investor Picture
Previous Investments
  • Beekeeper: $8000000 (Series A)
  • Actility: $75000000 (Later stage VC)
  • Fastly: $40000000 (Later stage VC)
  • Avrios: $14080000 (Later stage VC)
  • NetGuardians: $8500000 (Later stage VC)
  • Flyability: $8400000 (Early stage VC)
  • bexio: $7500000 (Later stage VC)
  • Rtbrick: $6000000 (Early stage VC)
  • ActLight: $1200000 (Later stage VC)
  • Insightness: (Other)
  • PIQ: (Later stage VC)
  • SignifAI: (Later stage VC)
  • Geosatis: (Early stage VC)
  • MATRIXX Software: (Later stage VC)

Swisscom Ventures

Zurich - Geneva, Switzerland

Investing In

Software (Web Marketplace Saas..) • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • CleanTech • HealthTech (& Fitness) • Material Science • Investment Management • Mobile

Description

Swisscom Ventures is the venture capital arm of Swisscom AG, the leading telecommunications and IT provider in Switzerland. Since their inception in 2007, they have invested in over 50 IT, digital media and telecommunication companies from offices in Switzerland (Zurich and Lausanne) and the USA (Silicon Valley). As a strategic investor, they offer entrepreneurs access to Swisscom technical infrastructure and market channels in addition to financial support. They focus on sectors of domain expertise such as Telco & IT Cloud, DeepTech and Cybersecurity as well as Big Data & AI related new business models where they leverage access to Swisscom's technology and market experts.

Seventure Partners
Investing in Software (Web Marketplace Saas..) &b...
 Basel, France
  • main investor picture
    Bruno Rivet
    Associate
  • main investor picture
    David Manjarres
    General Partner
  • main investor picture
    Emmanuel Fiessinger
    General Partner
  • main investor picture
    Pierre Aumeunier
    CFO
  • main investor picture
    Maxime Mandin
    Investment Director
  • main investor picture
    Isabelle de Cremoux
    Managing Partner
  • main investor picture
    Sébastien Groyer
    Partner
  • main investor picture
    Camille Curtil
    Associate
  • main investor picture
    Guillaume Echaudemaison
    Analyst
  • main investor picture
    Thibault Canton
    Partner
  • main investor picture
    Amanda Chaperot
    Partner
  • main investor picture
    Andreas Schenk
    Venture Partner
  • main investor picture
    Arthur Bourgade
    Analyst
  • main investor picture
    Guilhem Stoll
    Analyst
  • main investor picture
    Oxana Kukhaneva
    Venture Partner
  • main investor picture
    Quang Lê
    Analyst
  • main investor picture
    Rajesh Chopra
    Venture Partner
  • main investor picture
    Isabelle Cremoux
    Partner
  • main investor picture
    LaItitia Gerbe
    Partner
Investor Picture
Previous Investments
  • Axial Therapeutics: $37300000 (Series C)
  • Galecto: $92040000 (Later stage VC)
  • Launchmetrics: $50000000 (Later stage VC)
  • Tibot Technologies: $3300000 (Early stage VC)
  • Kinomap:
  • CouchCommerce: (Seed Round)
  • Axial Biotherapeutics: $37000000 (Series C)
  • Inalve: $2000000 (Series Unknown)
  • Sinay: $5000000 (Series Unknown)
  • Graphite Innovation & Technologies: $7000000 (Series A)
  • Clinical Microbiomics: $10000000 (Series Unknown)
  • Polaris: $6000000 (Seed)
  • Cytoki Pharma: $45000000 (Series A)
  • Citryll: $21000000 (Series B)
  • ENTEROME: $52000000 (Series E)
  • ENTEROME: $48000000 (Debt Financing)
  • ENTEROME: $34000000 (Series D)
  • ENTEROME: $16000000 (Series C)
  • ENTEROME: $15000000 (Series B)
  • ENTEROME: $10000000 (Series A)
  • ENTEROME: $2000000 (Seed)
  • MycoTechnology: $39000000 (Series D)
  • MycoTechnology: $42000000 (Series B)
  • MycoTechnology: $9000000 (Series A)
  • LNC Therapeutics: $7000000 (Series Unknown)
  • LNC Therapeutics: $8000000 (Series C)
  • LNC Therapeutics: $5000000 (Series B)
  • String Bio: (Series Unknown)
  • Microbiotica: $5000000 (Series Unknown)
  • machtfit: $3000000 (Series A)
  • Push Doctor: $26000000 (Series B)
  • Anaeropharma Science: $13000000 (Series Unknown)
  • Fluxome: $20000000 (Series B)
  • Fluxome: $7000000 (Series Unknown)
  • Glopal: $22000000 (Series A)
  • Domain Therapeutics: $41000000 (Series A)
  • Domain Therapeutics: $4000000 (Series Unknown)
  • Domain Therapeutics: $2000000 (Series Unknown)
  • Pitchy: $43000000 (Series B)
  • Pitchy: $7000000 (Series A)
  • Presto Engineering: (Series Unknown)
  • Presto Engineering: $2000000 (Series Unknown)
  • E-Blink: $4000000 (Series Unknown)
  • E-Blink: $9000000 (Series Unknown)
  • E-Blink: $8000000 (Series Unknown)
  • Abalos Therapeutics: $36000000 (Series A)
  • Dopavision: $14000000 (Series A)
  • Oxxon Therapeutics: $24000000 (Series Unknown)
  • Proteon Pharmaceuticals: $25000000 (Series Unknown)
  • Proteon Therapeutics: $25000000 (Post Ipo Equity)
  • Aenitis Technologies: (Series Unknown)
  • Scipio Bioscience: $7000000 (Series A)
  • Scipio Bioscience: $1000000 (Seed)

Seventure Partners

Basel, France

Investing In

Software (Web Marketplace Saas..) • Other • IT (& TMT) • Media • BioTech • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • Retail (& E-Commerce) • CleanTech • HealthTech (& Fitness) • Food & Beverage • Material Science • Medical Devices (& Hospital Services) • DeepTech • Healthcare (& Wellness) • Mobile • Consumer • Pharmaceutical (& Medicine)

Description

Seventure Partners is a venture capital firm that seek to invest in the hardware and telecommunication, information technology and life sciences sectors. The firm was founded in 1997 and is based in Paris, France.

Investor Picture
Previous Investments
  • Rtbrick: $6000000

Dominique Megret

Zurich Switzerland, Switzerland

Investing In

Software (Web Marketplace Saas..) • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • CleanTech • HealthTech (& Fitness) • Material Science

Hans Dellenbach
Investing in AgroTech • Energy • Materi...
 Zurich, Switzerland
Investor Picture
Previous Investments
  • Powerhouse Dynamics:
  • Future Meat Technologies: $14000000 (Later stage VC)
  • AlphaICs: $8000000 (Early stage VC)
  • Open Mineral: $5500000 (Early stage VC)
  • Sofi Filtration: $3530000 (Early stage VC)
  • enspired: $9000000 (Series A)
  • Aquaspy: $6000000 (Series Unknown)

Hans Dellenbach

Zurich, Switzerland

Investing In

AgroTech • Energy • Material Science

Description

Senior Partner and CFO at Emerald Technology Ventures

Markus Decker
Investing in Software (Web Marketplace Saas..) &b...
 Zurich Switzerland, Switzerland
Investor Picture
Previous Investments
  • Dentalia: $5730000

Markus Decker

Zurich Switzerland, Switzerland

Investing In

Software (Web Marketplace Saas..) • IT (& TMT) • Media • Education • BioTech • Hardware (& Manufacturing) • Material Science • Medical Devices (& Hospital Services)

Investor Picture
Previous Investments
  • Bikemap: $790000

Jurgen Habichler

Zurich Switzerland, Switzerland

Investing In

Software (Web Marketplace Saas..) • IT (& TMT) • Hardware (& Manufacturing) • Energy • Retail (& E-Commerce) • CleanTech • Food & Beverage • Material Science

Description

Jurgen Habichler is the Founder and serves as Managing Partner and an Investment Committee Member at Jadeberg Partners. He also serves as Board Member at MCS Solutions. In 1995 he laid the foundation for the establishment of Ooe Data Highway Development, one of the first alternative provider of telecommunications and Internet services in Austria. Alongside expert at the European Commission, he worked in investment banking at Morgan Stanley. After receiving his MBA in 2001 at the Wharton Business School (USA) at Siebel Systems in their Silicon Valley office, where he was awarded the "Siebel Product Marketing Star Award" and the "Siebel CEO Award". As of 2004, Jurgen worked at Atlas Venture, a global venture capital firm operierendem where he spearheaded the development of the Cleantech division with. He is Board Member at Contentsphere International.

Vanessa Hallik
Investing in Software (Web Marketplace Saas..) &b...
 New York, U.S.A. - Global: U.S.A., Australia, Canada, Germany, U.K., Israel, France, Italy, Spain, Netherlands, Belgium, Switzerland, Denmark, Finland, Luxembourg, Malta, Iceland
Investor Picture

Vanessa Hallik

New York, U.S.A. - Global: U.S.A., Australia, Canada, Germany, U.K., Israel, France, Italy, Spain, Netherlands, Belgium, Switzerland, Denmark, Finland, Luxembourg, Malta, Iceland

Investing In

Software (Web Marketplace Saas..) • AgroTech • Retail (& E-Commerce) • IoT (& Wearables) • CleanTech • Impact • Material Science • Online Social • Consumer • Woman Focused

Description

Founder & CEO of Another Tomorrow. Early stage investor in companies that are positive catalysts for system-wide change.

Investor Picture
Previous Investments
  • ID Genève: $2000000 (Seed)
  • OceanSafe: (Seed)

Exelixis Capital

Zurich, Switzerland

Investing In

CleanTech • Blockchain (& Cryptos) • Material Science • LegalTech

Kyle Kurpinski
Investing in Software (Web Marketplace Saas..) &b...
 Seattle - Washington, U.S.A. - Global: U.S.A., Australia, Canada, Germany, U.K., Israel, France, Italy, Spain, Netherlands, Belgium, Switzerland, Denmark, Finland, Luxembourg, Malta, Iceland
Investor Picture
Previous Investments
  • Metagenomi: $180000000 (Series B)
  • Culture Biosciences: $80000000 (Series B)
  • Culture Biosciences: (seed)
  • Lassogen: $4500000 (Seed Round)
  • Mantra Bio: $25000000 (Series A)
  • Atomwise: $45000000 (Series A)
  • Locus Biosciences: $19000000 (Series A)
  • Karius: $59000000 (Series A)
  • Guardant Health: $360000000 (Series E)
  • Guardant Health: $100000000 (Series D)
  • Clear Labs: $16000000 (Series B)
  • Color Genomics: $45000000 (Series B)
  • Diassess: $13000000 (Series A)
  • Oscar Health: $150000000 (Series C)
  • PicnicHealth: (Seed Round)

Kyle Kurpinski

Seattle - Washington, U.S.A. - Global: U.S.A., Australia, Canada, Germany, U.K., Israel, France, Italy, Spain, Netherlands, Belgium, Switzerland, Denmark, Finland, Luxembourg, Malta, Iceland

Investing In

Software (Web Marketplace Saas..) • BioTech • AgroTech • Energy • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Impact • Material Science • Robotics

Description

Most Interested In

I'm most interested in companies building deep core technologies to solve complex challenges in human health and planetary resiliency. I'm particularly drawn towards data-driven companies, and I focus heavily on those innovating at the intersection of data science and life science. I'm intrigued by the possibilities of using robotics, automation, miniaturization, and new high-throughput techniques to rapidly generate novel and actionable insights for users.

Not Interested In

I generally do not invest companies that lack a clear and defensible core technology.

Emerald Technology Ventures
Investing in AgroTech • Hardware (& Manufact...
 Zürich - Zurich, Canada
  • main investor picture
    Hans Dellenbach
    Partner
  • main investor picture
    Helge Daebel
    Partner
  • main investor picture
    Charles Vaslet
    Partner
  • main investor picture
    Markus Moor
    Partner
  • main investor picture
    Frank Balas
    Investor
  • main investor picture
    Simone Riedel Riley
    Head of Techfund
  • main investor picture
    Gina Domanig
    Managing Partner
  • main investor picture
    Philipp Hasler
    Investor
  • main investor picture
    Graham Carey
    Investor
  • main investor picture
    Mehran Zaker
    Investor
  • main investor picture
    Cédric Mutz
    Investment Director
  • main investor picture
    Annina Winkler
    Investor
  • main investor picture
    Michal Natora
    Investor
  • main investor picture
    Alex Tepper
    Managing Director
  • main investor picture
    Anandhi Gokhale
    Investor
  • main investor picture
    Ben Abadi
    Investor
  • main investor picture
    Christoph W. Frei
    Partner
  • main investor picture
    Fabian Braunwalder
    Investor
  • main investor picture
    Clayton MacDougald
    Investor
  • main investor picture
    Kelven Lam
    Investor
Investor Picture
Previous Investments
  • Powerhouse Dynamics:
  • Future Meat Technologies: $14000000 (Later stage VC)
  • Open Mineral: $5500000 (Early stage VC)
  • SynapSense: $4000000 (Series Unknown)
  • SynapSense: $16000000 (Series C)
  • SynapSense: $5000000 (Series Unknown)
  • SynapSense: $7000000 (Series C)
  • SynapSense: $11000000 (Series B)
  • SDC Materials: $14000000 (Series B)
  • SDC Materials: $6000000 (Series Unknown)
  • bNovate Technologies: $13000000 (Series C)
  • Aganova: (Series Unknown)
  • Sofi Filtration: $4000000 (Series Unknown)
  • Fido Tech: $7000000 (Series Unknown)
  • Eologix: $6000000 (Series Unknown)
  • Librestream Technologies: $24000000 (Series D)
  • Librestream Technologies: $11000000 (Series Unknown)
  • Visedo: $16000000 (Debt Financing)
  • P97 Networks: $9000000 (Series A)
  • Pelamis Wave Power: $8000000 (Series Unknown)
  • AZZURRO Semiconductors: $19000000 (Series Unknown)
  • XunLight: $11000000 (Series C)
  • XunLight: $22000000 (Series B)
  • XunLight: $7000000 (Series A)
  • enspired: $9000000 (Series A)
  • Aquaspy: $6000000 (Series Unknown)
  • INGU: $5000000 (Series A)
  • sewts: $8000000 (Series A)
  • AlphaICs: $8000000 (Series B)
  • AlphaICs: $3000000 (Seed)
  • Quantum Motion: $51000000 (Series B)
  • Actnano: $22000000 (Series B)
  • Actnano: $12000000 (Series A)
  • Sielo: $11000000 (Series Unknown)
  • Sielo: $6000000 (Series A)

Emerald Technology Ventures

Zürich - Zurich, Canada

Investing In

AgroTech • Hardware (& Manufacturing) • Energy • Sales (& Marketing) • IoT (& Wearables) • CleanTech • A.I. (& Big Data) • Web Security (& Privacy) • Autonomous vehicles (& Cars) • Logistics (& Distribution) • Material Science • Robotics • Investment Management • Mobility • Consumer • UrbanTech

Description

Emerald Technology Ventures is a venture capital firm which focuses on industrial technology investments. The firm invests in a wide range of sectors including advanced material, agriculture, energy, industrial information technology and water. It was founded in 2000 and is based in Zurich, Switzerland. It invests in early and expansion-stage firms, primarily in Europe and North America.

Endeavour Vision SA
Investing in Software (Web Marketplace Saas..) &b...
 Zurich - Geneva, Switzerland
  • main investor picture
    Dominique Pitteloud
    Managing Partner
  • main investor picture
    Bernard Vogel
    Managing Partner
  • main investor picture
    Damien Tappy
    President and Managing Partner
  • main investor picture
    Robert O'Holla
    Operating Partner
  • main investor picture
    Dominik Ellenrieder
    Operating Partner
  • main investor picture
    Sven Lingjaerde
    Managing Partner
  • main investor picture
    Alexander Schmitz
    Partner
  • main investor picture
    Fernando Pacheco
    Investment Manager
  • main investor picture
    Rob Barmann
    Senior Investment Director
  • main investor picture
    Jacques Essinger
    Operating Partner
Investor Picture
Previous Investments
  • CeQur: $100000000 (Series C)
  • Chrono Therapeutics: $47600000 (Series B)
  • Gynesonics: $43000000 (Private Equity Round)
  • VertiFlex: $40000000 (Venture Round)
  • ReShape Medical: $38000000 (Series D)
  • EndoStim: $25000000 (Series D)
  • Venture Med Group: $15000000 (Series B)
  • Sophia Genetics: $13750000 (Series B)
  • Amplidata: $11000000 (Series D)
  • Kobojo: $7000000 (Series B)

Endeavour Vision SA

Zurich - Geneva, Switzerland

Investing In

Software (Web Marketplace Saas..) • IT (& TMT) • Media • BioTech • Hardware (& Manufacturing) • Material Science • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Pharmaceutical (& Medicine)

Description

Endeavour Vision is a growth investor in exceptional private medtech companies, and an ideal partner for medtech entrepreneurs. Headquartered in Geneva, Switzerland with a presence in the United States, the Endeavour Vision team comprises experienced investors, seasoned entrepreneurs and medtech specialists, all committed to helping entrepreneurs grow and develop thriving businesses. Endeavour’s latest $275 million fund is fully dedicated to investing in European and US medtech companies that seek worldwide growth and aim to improve the quality and cost of care for patients across the globe.

Join the community

Connect with investors & startup founders

Comprehensive Guides to Finding Startup Investorsin Switzerland

By clicking on "Create Account" you accept our terms of service

Already have an account?
Login
founder clement

Clément Perrot - Associate Partners @ Angels Partners

"Angels Partners is here to help startup founders secure meetings with investors.
We provide access to a number of services centered around fundraising."

taylor founder testimonial

Kevin Creusy - Founder & CEO, Upfluence



"I launched a campaign and booked 12 meetings in three weeks. There just isn't anything comparable online yet."

founder testimonial

Alex Cammarano - Founder of Daylighted



"Within a few weeks, we launched a successful investor outreach campaign and arranged dozens of pitches."


Create An Account
Copyright © 2024 - All trademarks and copyrights belong to their respective owners.
32 New Startups Started their fundraising over the last 7 days